AMAN Amanat Acquisition Corp.

NEUTRAL Impact: 4/10 424B4
Horizon weeks Filed May 20, 2026 Processed 25d 22h ago SEC 0001213900-26-059197
Prospectus supplement
Latest settled — T+5d ⚠ clustered
AMAN ▲ +0.40% at T+5d
NEUTRAL call ✓ call won +0.40% · α vs SPY -1.41% · entry $10.10 → $10.14
Next anchor: T+20d in 3d
Last close $10.10 (close Jun 12) · +0.00% from $10.10 entry
Entry anchored
May 20, 2026
via day open
T+1d
+0.30%
call +0.30% · α +0.10%
$10.13
settled 25d ago
T+5d
+0.40%
call +0.40% · α -1.41%
$10.14
settled 18d ago
T+20d
call — · α —
in 3d
T+60d
call — · α —
in 2mo

Executive Summary

Amanat Acquisition Corp. priced its SPAC IPO of 7.5 million Class A ordinary shares at $10.00 per share, raising $75 million in gross proceeds, plus a $3 million private placement from the sponsor. The blank-check company targets a healthcare/life sciences business within 24 months. Public investors face immediate dilution from founder shares purchased at ~$0.012 per share.

Key Financial Metrics

Offering Size
$75.0M
Dilution
19.4%

Actionable Insight

Monitor for any business combination announcements within the 24-month window. The experienced management team may accelerate deal sourcing. Public shareholders should be aware of potential dilution from founder shares and the risk of no deal being completed.

Key Facts

  • 7,500,000 Class A ordinary shares offered at $10.00 per share, raising $75 million
  • Sponsor purchased 300,000 private placement shares at $10.00 each, totaling $3 million
  • No warrants issued, unlike many SPAC IPOs
  • 24-month window to complete a business combination, focusing on healthcare/life sciences
  • Founder shares 2,156,250 at ~$0.012 per share, representing ~20% of post-offering shares
  • Underwriter: Leerink Partners; trust account holds $75 million including $2.25 million deferred underwriting fees

Financial Impact

$75 million gross IPO proceeds plus $3 million private placement, with $75 million deposited in trust

dilutioncash position

Risk Factors

  • Significant dilution from founder shares acquired at nominal price
  • No target identified yet; risk of failing to complete a business combination within 24 months
  • Potential for high redemptions at deal time, reducing trust account cash available

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B4 Filing (Primary)0001213900-26-059197
Document: 0001213900-26-059197-index-headers.html0001213900-26-059197
Document: 0001213900-26-059197-index.html0001213900-26-059197
Document: 0001213900-26-059197.txt0001213900-26-059197
8 reports for AMAN
Performance horizon
Filters
Rows
Reports for AMAN — sortable, filterable
Type Now
May 27, 2026
18d ago
8-K
NEUTRAL ★ 3/10
$10.14 $10.08▼ −0.59%▼ −0.91%$10.10 (−0.39%)
May 21, 2026
24d ago
8-K
NEUTRAL ★ 5/10
$10.13 $10.14▲ +0.10%▼ −1.50%$10.10 (−0.30%)
May 20, 2026
26d ago
424B4
NEUTRAL ★ 4/10
$10.10 $10.14▲ +0.40%▼ −1.41%$10.10 (+0.00%)
May 19, 2026
26d ago
3
NEUTRAL ★ 1/10
$10.10 $10.14▲ +0.40%▼ −1.41%$10.10 (+0.00%)
May 19, 2026
26d ago
3
NEUTRAL ★ 2/10
$10.10 $10.14▲ +0.40%▼ −1.41%$10.10 (+0.00%)
May 19, 2026
26d ago
3
NEUTRAL ★ 2/10
$10.10 $10.14▲ +0.40%▼ −1.41%$10.10 (+0.00%)
May 19, 2026
26d ago
Press Release
NEUTRAL ★ 4/10
$10.01 $10.13▲ +1.20%▼ −1.05%$10.10 (+0.90%)
May 14, 2026
4w ago
S-1/A
NEUTRAL ★ 4/10
awaiting T+5
Showing 8 of 8

US Market Status

Market Closed — Opens in 5h 8m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access